Standard-of-care combination treatment rescues GFR decline and cardiac damage in a novel cardiovascular-kidney-metabolic syndrome mouse model with chronic kidney disease and HFpEF
Event: Frontiers in CardioVascular Biomedicine 2024
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Late-breaking science poster session
